History
  • No items yet
midpage
Quinn v. Walgreen Co.
958 F. Supp. 2d 533
S.D.N.Y.
2013
Read the full case

Background

  • Plaintiffs Quinn and Ducorsky filed a putative class action against Walgreens alleging its glucosamine/chondroitin supplements falsely claim to “help rebuild cartilage.”
  • Plaintiffs bought Walgreens’ Triple Strength product (Quinn bought in NY & CT; Ducorsky in NY) and allege they relied on the labeling and would not have purchased the products had they known the representations were false.
  • Walgreens moved to stay this case under the first-filed rule pending disposition of an earlier-filed Illinois action (Guilin) and alternatively moved to dismiss under Fed. R. Civ. P. 12(b)(1) and 12(b)(6).
  • The Illinois action involves a different named plaintiff, asserts California law claims, and seeks certification of a multi-state class that could potentially include NY and CT purchasers but has not been certified.
  • The complaint asserts claims under N.Y. Gen. Bus. Law § 349 and Conn. Gen. Stat. § 42-110a et seq., breach of express warranty, and unjust enrichment; plaintiffs cite scientific studies to allege the labeling is affirmatively false.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether to stay under the first-filed rule Guilin is related; stay promotes judicial economy Guilin is not identical; different plaintiffs and laws; stay unnecessary Denied — first-filed rule inapplicable because parties and issues are not the same and Guilin may not be dispositive
Standing to assert claims for products not purchased Plaintiffs can represent purchasers of substantially similar products; class-stage is proper time to resolve scope Named plaintiffs lack standing to sue on products they did not buy Denied — plaintiffs have standing for now; similarity of products makes this a class-certification issue
Sufficiency of consumer-protection claims (NY GBL § 349 and CUTPA) Labeling “help rebuild cartilage” is false/deceptive; scientific studies support falsity Statements are non-actionable or merely lack substantiation; studies are weak Denied — claims plausibly plead deception; falsity is a factual question unsuited to dismissal
Breach of express warranty and unjust enrichment Warranty (100% satisfaction) and retention of benefits support claims Plaintiffs failed to give timely notice for warranty; unjust enrichment not warranted Warranty claim dismissed for failure to plead notice; unjust enrichment claim survives

Key Cases Cited

  • Lujan v. Defenders of Wildlife, 504 U.S. 555 (constitutional standing requires injury in fact, causation, redressability)
  • Ashcroft v. Iqbal, 556 U.S. 662 (2009) (pleading standard; plausibility required)
  • Bell Atl. Corp. v. Twombly, 550 U.S. 544 (2007) (plausibility standard for pleadings)
  • First City Nat’l Bank & Trust Co. v. Simmons, 878 F.2d 76 (2d Cir.) (first-filed rule favors first suit)
  • Employers Ins. of Wausau v. Fox Entm’t Grp., Inc., 522 F.3d 271 (2d Cir.) (considerations of docket administration under first-filed rule)
  • Pelman ex rel. Pelman v. McDonald’s Corp., 396 F.3d 508 (2d Cir.) (Section 349 not subject to Rule 9(b))
Read the full case

Case Details

Case Name: Quinn v. Walgreen Co.
Court Name: District Court, S.D. New York
Date Published: Aug 7, 2013
Citation: 958 F. Supp. 2d 533
Docket Number: No. 12 CV 8187(VB)
Court Abbreviation: S.D.N.Y.